Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

316.38
Delayed Data
As of 4:00pm ET
 +1.08 / +0.34%
Today’s Change
185.46
Today|||52-Week Range
323.61
+44.07%
Year-to-Date
Sarepta's (SRPT) DMD Gene Therapy BLA Gets FDA Priority Review
12:07pm / Zacks.com - Paid Partner Content
Merck (MRK) Keytruda Advanced Gastric Cancer Study Meets Goal
Nov 23 / Zacks.com - Paid Partner Content
2 Stocks Near 52-Week Highs That Could Climb Higher
Nov 28 / MotleyFool.com - Paid Partner Content
GSK to Withdraw Blenrep From U.S. Market on FDA Request
Nov 23 / Zacks.com - Paid Partner Content
Cathie Wood Is Selling This High-Flying Stock. Here's Why You Should Buy It Instead
Nov 25 / MotleyFool.com - Paid Partner Content
2 Stocks to Buy That Will Grow Your Money Over Time
Nov 23 / StockNews.com - Paid Partner Content
BioMarin (BMRN) Up After FDA Scraps AdCom Meet for BLA Filing
Nov 24 / Zacks.com - Paid Partner Content
Is This Biotech Stock a Buy for Under $3?
Nov 23 / StockNews.com - Paid Partner Content
AbbVie's (ABBV) Skyrizi Gets EU Nod for Crohn's Disease
Nov 24 / Zacks.com - Paid Partner Content
Should iShares MSCI USA Min Vol Factor ETF (USMV) Be on Your Investing Radar?
Nov 23 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close315.30
Today’s open315.50
Day’s range312.63 - 317.21
Volume59,387
Average volume (3 months)1,374,472
Market cap$80.3B
Data as of 4:00pm ET, 11/29/2022

Growth & Valuation

Earnings growth (last year)-12.91%
Earnings growth (this year)+12.60%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+22.47%
P/E ratio25.0
Price/Sales7.51
Price/Book7.89

Competitors

 Today’s
change
Today’s
% change
REGNRegeneron Pharmaceut...-5.37-0.72%
----
ZTSZoetis Inc-0.28-0.19%
GSKGlaxoSmithKline+0.61+1.81%
Data as of 4:00pm ET, 11/29/2022

Financials

Next reporting dateFebruary 1, 2023
EPS forecast (this quarter)$3.62
Annual revenue (last year)$7.6B
Annual profit (last year)$2.3B
Net profit margin30.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Boston, Massachusetts

Forecasts